Clinical Trials Sponsored by Instituto Lala

Total 74339 results

National Cancer Institute (NCI)

Recruiting

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

Kaposi's Sarcoma | Human Immunodeficiency Virus | Castleman's Disease | Viral-Associated Cancer

United States
National Cancer Institute (NCI)

Recruiting

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

Lymphoma | Epstein-Barr Virus Infections | Lymphoproliferative Disorder | Disorders, Lymphoproliferative

United States
National Eye Institute (NEI)

Recruiting

Dark Adaptation in Participants With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Cancer Institute (NCI)

Recruiting

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Ependymoma | Medulloblastoma | Pineal Region Tumors | Choroid Plexus Tumors | Atypical/Malignant Meningioma

United States
National Cancer Institute (NCI)

Recruiting

Prospective Evaluation and Molecular Profiling in People With Gastric Tumors

Stomach Neoplasms | Stomach Cancer

United States
National Cancer Institute (NCI)

Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Renal Cell Cancer

United States
National Eye Institute (NEI)

Recruiting

Natural History of Spinocerebellar Ataxia Type 7 (SCA7)

Spinocerebellar Ataxia

United States
National Cancer Institute (NCI)

Recruiting

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Sarcoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neurofibroma, Plexiform | Leukemia, Promyelocytic, Acute

United States
National Cancer Institute (NCI)

Recruiting

Rapid Autopsy and Procurement of Cancer Tissue

Mesothelioma | Thymus Tumors | Adoptive Cellular Therapy | Genitourinary Cancers | Lung Cancers

United States
National Cancer Institute (NCI)

Recruiting

Tissue Collection for Studies of Lymph Cancer

Lymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease | Leukemia-Lymphoma, Adult T-Cell | Lymphomatoid Granulomatosis

United States, Jamaica
National Cancer Institute (NCI)

Recruiting

Clinical and Genetic Studies of Li-Fraumeni Syndrome

Neoplasms | Li-Fraumeni Syndrome | Tp53 Mutations

United States
National Cancer Institute (NCI)

Recruiting

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

Lymphoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer

United States
National Eye Institute (NEI)

Recruiting

Study of Dark Adaptation in Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Eye Institute (NEI)

Recruiting

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Retinal Disease | Genotype

United States
National Cancer Institute (NCI)

Recruiting

Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies

Sarcoma | Neuroblastoma | Retinoblastoma | Renal Cancer | Endocrine Tumors

United States
National Cancer Institute (NCI)

Recruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Chronic Lymphocytic Leukemia (CLL) | Hairy Cell Leukemia (HCL) | Cutaneous T Cell Lymphoma (CTCL) | Non-Hodgkins Lymphoma (NHL) | Adult T Cell Lymphoma (ATL)

United States
National Cancer Institute (NCI)

Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Thyroid Neoplasms | Neuroblastoma | Parathyroid Neoplasms | Endocrine Tumors | Adrenal Neoplasm

United States
National Cancer Institute (NCI)

Recruiting

Collection of Tissue Samples for Cancer Research

Neoplasms | Multiple Myeloma | Myelodysplastic Syndrome | Lymphomas

United States, Canada
National Cancer Institute (NCI)

Recruiting

Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
National Cancer Institute (NCI)

Recruiting

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

Melanoma | Dysplastic Nevus Syndrome

United States
National Cancer Institute (NCI)

Recruiting

Collection of Blood From Patients With Cancer

Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer | Liver Cancer

United States
National Cancer Institute (NCI)

Recruiting

Cancer in Inherited Bone Marrow Failure Syndromes

Fanconi Anemia | Dyskeratosis Congenita | Diamond Blackfan Anemia | Shwachman Diamond Syndrome | Inherited Bone Marrow Failure Syndrome, Aplastic Anemia

United States
National Cancer Institute (NCI)

Recruiting

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Kidney Cancer | Renal Cell Carcinoma | Urologic Malignant Disorders | Familial Renal Cancer (FRC) | Clear Cell Renal Cancer

United States
National Cancer Institute (NCI)

Completed

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

Neurofibromatosis Type 1 | Legius Syndrome

United States
National Cancer Institute (NCI)

Enrolling by invitation

Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients

Sleep Circadian Rhythms | Chronodisruption

United States
National Cancer Institute (NCI)

Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Lymphoma, B-Cell | Leukemia, B-cell | Lymphoma, Hodgkins | Lymphoma, Non-hodgkins

United States
National Cancer Institute (NCI)

Suspended

Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors

Neoplasms | Solid Tumors

United States
National Cancer Institute (NCI)

Enrolling by invitation

Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity

Cancer | Solid Tumors | Neoplasm

United States
National Cancer Institute (NCI)

Suspended

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Lymphoma | Leukemia

United States
National Cancer Institute (NCI)

Completed

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Sarcoma | Neuroblastoma | Solid Tumors | Brain Tumors | Pediatric Cancers

United States
National Cancer Institute (NCI)

Active, not recruiting

Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data

Melanoma | Breast Cancer | Lung Cancer | Prostate Cancer | Cutaneous T-Cell Lymphoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Breast Mammogram and Tissue Study

Breast Neoplasms

United States
National Cancer Institute (NCI)

Enrolling by invitation

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Urethral Neoplasms | Urethral Cancer | Neoplasms, Urethral | Cancer of the Urethra

United States
National Cancer Institute (NCI)

Completed

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Ependymoma | Medulloblastoma | PNET | Diffuse Intrinsic Pontine Glioma | Germinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Neurofibromatosis 1 | Neurofibroma, Plexiform | Neurofibromatosis Type 1 | NF1

United States
National Cancer Institute (NCI)

Completed

Validating Pain Scales in Children and Young Adults

Leukemia | Solid Tumor | Sickle Cell Disease | Neurofibromatosis

United States
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
National Eye Institute (NEI)

Completed

Intestinal Bacteria and Ocular Inflammatory Disease

Uveitis

United States
National Cancer Institute (NCI)

Active, not recruiting

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Enrolling by invitation

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Breast Cancer | Ovarian Cancer | Uterine Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Esophageal Cancer in Northeastern Iran

Esophageal Cancer | GI Disease

Iran, Islamic Republic of
National Eye Institute (NEI)

Completed

Biomarkers in Ocular Inflammation and Uveitis

Uveitis | Ocular Inflammation

United States
National Cancer Institute (NCI)

Terminated

LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | Lung Cancer | Adenocarcinoma of Lung

United States
National Eye Institute (NEI)

Terminated

Visual Motor Coordination

Neurodegenerative Diseases | Healthy Volunteer

United States
National Eye Institute (NEI)

Active, not recruiting

Repository for Inherited Eye Diseases

Retinitis Pigmentosa | Inherited Ophthalmic Diseases

United States
National Cancer Institute (NCI)

Completed

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Solid Tumors

United States
National Cancer Institute (NCI)

Active, not recruiting

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

Follicular Lymphoma | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | NHL | B-All | ALL | Large Cell Lymphoma | B-NHL | B-Non Hodgkin Lymphoma | B-precursor ALL

United States
National Cancer Institute (NCI)

Withdrawn

N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer

Castration Resistant Prostate Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

Cancer | Hereditary Neoplasms | Genetic Predisposition to Cancer | Environment

United States

Clinical Trials Sponsored by Instituto Lala

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations